Psoriatic Arthritis vs. Gout: Understanding the Distinctions

Psoriatic arthritis (PsA) and gout are both forms of inflammatory arthritis, characterized by painful swelling in various joints, including the fingers, toes, knees, and ankles. While they may present with some overlapping symptoms and share certain triggers, these conditions originate from distinct pathophysiological mechanisms and therefore require different management and treatment approaches. Understanding these key differences is crucial for accurate diagnosis and effective care. This article aims to clarify the specific symptoms, underlying causes, diagnostic procedures, and treatment strategies for each condition, also exploring the intriguing connection that exists between psoriatic disease and gout.

Verywell / Jessica Olah

Symptoms: Distinguishing Features

While both psoriatic arthritis and gout manifest as joint pain and swelling, a closer look at their specific symptom profiles often reveals crucial differences. Recognizing these unique indicators can help individuals and healthcare providers differentiate between the two conditions, paving the way for a more targeted diagnostic process. It is important to note that symptom presentation can vary among individuals, making a comprehensive medical evaluation essential.

Psoriatic Arthritis

Psoriatic arthritis affects less than 1% of the American population. While this figure may seem modest, a significant portion of PsA cases occurs in individuals already living with psoriasis, an inflammatory skin condition marked by an overproduction of skin cells that form characteristic red patches covered in silvery scales. The National Psoriasis Foundation estimates that nearly one-third of people with psoriasis will eventually develop PsA, underscoring the importance of early assessment for joint pain in this population.

The symptoms of PsA often include:

• Pain and stiffness in multiple joints: This can affect joints on one or both sides of the body, sometimes asymmetrically.
• Large joint involvement: While any joint can be affected, lower extremities such as the knees and ankles are particularly common sites of inflammation.
• Nail involvement: Distinctive changes like nail pitting, crumbling, ridging, and separation of the nail from its bed are strong indicators.
• Psoriasis skin symptoms: The presence of skin plaques, similar to those seen in psoriasis, frequently accompanies joint symptoms.
• Spine involvement (Psoriatic Spondylitis): This causes stiffness and pain in the back or neck, often making bending difficult.
• Enthesitis: Tender spots occur where tendons and ligaments attach to bone, commonly affecting the backs of the heels and the soles of the feet.
• Dactylitis: Often referred to as “sausage digits,” this extreme swelling of an entire finger or toe gives it a sausage-like appearance.
• Eye inflammation: Conditions like uveitis, which can cause eye redness, pain, blurred vision, and light sensitivity, may also occur.

Gout

Gout is characterized by its distinct pattern of intermittent episodes, known as "gout attacks," during which affected joints suddenly become red, hot, and severely swollen. These attacks often strike without warning, frequently in the middle of the night, rousing individuals from sleep with excruciating pain. While the acute phase of an attack typically lasts between seven and 14 days, some lingering discomfort may persist for days or weeks afterward, especially in severe or chronic cases.

Key symptoms of gout include:

• Excruciating pain in the big toe: The first metatarsophalangeal joint of the big toe is the most common site for a gout attack, a condition known as podagra. The pain can be so intense that even the slightest touch, like bedding, becomes unbearable, accompanied by warmth and redness.
• Pain in other joints: While the big toe is primary, gout can affect any joint. Other common sites include the feet, ankles, knees, wrists, thumbs, and elbows. Polyarticular attacks, affecting more than three joints simultaneously, can occur in a significant percentage of individuals, particularly women.
• Lumps around the joints (Tophi): In chronic or severe cases, deposits of uric acid crystals can form visible lumps called tophi, typically found just beneath the skin and around joints. These can contribute to bone and cartilage damage over time.
• Spine involvement: While rare, gout can affect the spine, particularly the lumbar (lower) spine, and even the sacroiliac joints that connect the sacrum to the hip bone.
• Lingering discomfort: Even after the peak intensity of a gout attack (which usually occurs 12–24 hours after onset) subsides, residual joint discomfort can persist for days or even weeks.
• Warmth and redness: Affected joints typically exhibit significant warmth and redness.
• Limited range of motion: As an attack progresses, the affected joint may become stiff and difficult to move, significantly limiting its normal range of motion.

PsA–Gout Connection

An important clinical observation is the increased risk of gout in individuals diagnosed with psoriatic disease (psoriasis and/or psoriatic arthritis). This connection, recognized for decades, is believed to stem from the role of uric acid. Uric acid is a natural byproduct of the body's breakdown of purines, compounds found in human cells and various foods. In the context of psoriatic disease, elevated uric acid levels may contribute to both the excessive production of skin cells and systemic inflammation. For those with gout, this uric acid accumulates in and around the joints, triggering painful attacks.

A 2014 study in Drug Development Research highlighted the prevalence of high uric acid blood levels (hyperuricemia) in 20% of 338 psoriasis patients, identifying psoriasis as a strong predictor of this condition. Further cementing this link, a substantial 2015 study tracked 98,810 individuals in the United States with psoriasis and/or PsA over several years. This research revealed that individuals with psoriasis had nearly double the risk of developing gout, while those with both psoriasis and PsA faced a five-fold increased risk. These groundbreaking findings underscored the need for clinicians to consider gout as a potential cause of joint inflammation in patients with psoriatic disease, even when psoriatic arthritis is already present.

Causes: Distinct Origins

The fundamental difference between psoriatic arthritis and gout lies in their root causes. PsA is classified as an autoimmune disease, where the body's immune system mistakenly attacks its own healthy tissues, primarily the joints and sometimes the skin. Gout, in contrast, is primarily a metabolic disorder, resulting from an accumulation of uric acid within the blood and tissues, which eventually precipitates as crystals in the joints, triggering inflammation.

Psoriatic Arthritis

The exact cause of psoriatic arthritis remains a subject of ongoing research, but it is clear that the immune system plays a central role in its development, as it does in psoriasis. Genetic factors are believed to significantly influence the susceptibility to PsA. The human leukocyte antigen (HLA) complex, a family of genes vital for immune system function and for distinguishing the body's own proteins from foreign invaders like viruses and bacteria, is particularly well-studied. Variations within HLA genes are strongly linked to PsA development, its severity, specific types, and overall disease progression.

Family history also plays a significant role in PsA, with psoriatic disease often appearing to run in families. Although a definitive inheritance pattern for PsA has yet to be fully elucidated, approximately 40% of individuals diagnosed with PsA have at least one close family member affected by either psoriasis or PsA. Beyond genetics, environmental factors are thought to act as potential triggers, especially in genetically predisposed individuals. Injuries, infections, chronic stress, and exposure to certain toxins can all contribute to the onset of PsA.

Risk factors for PsA include:

• A family history: Genetic predisposition significantly increases risk.
• Psoriasis: Having psoriasis is the most substantial risk factor, with a considerable percentage of psoriasis patients eventually developing PsA.
• Age: While PsA can affect individuals of any age, it most frequently emerges in adults between 35 and 55.
• Smoking: Smoking is associated with an increased risk for PsA, not through a direct causal link, but rather due to the chronic inflammation it promotes throughout the body.

Gout

Historically, gout was often termed the "rich man's disease" or the "disease of kings," erroneously believed to exclusively affect wealthy men indulging in rich diets and excessive alcohol. However, modern medical understanding clarifies that gout is primarily a metabolic condition driven by elevated uric acid levels in the blood, often influenced by dietary choices rather than socioeconomic status. Genetic factors also play a substantial role in predisposing individuals to gout.

Dozens of genes have been identified as contributing to gout susceptibility. Among the most influential are SLC2A9 and ABCG2. The SLC2A9 gene provides instructions for a protein in the kidneys that regulates urate levels in the body. Variations in this gene can lead to increased reabsorption of urate back into the bloodstream and reduced excretion through urine. The ABCG2 gene, conversely, instructs the body to produce a protein that facilitates the release of urate from the body. Genetic alterations in ABCG2 can impair this protein's ability to excrete urate into the gut, resulting in elevated blood uric acid levels.

Beyond genetics, various non-genetic factors can contribute to the development of gout and trigger acute attacks. These factors increase the overall urate levels in the body, most notably the consumption of foods and beverages rich in purines. Foods such as seafood, red meat, alcohol, and sugary drinks are known to be high in purines, which are then broken down into uric acid.

Risk factors for gout include:

• Being male: Males are approximately three times more likely to develop gout than females, primarily due to higher uric acid levels throughout most of their lives and lower levels of estrogen, a hormone that helps remove urate from the body.
• Age: The risk of gout increases with advancing age. In females, the risk typically rises after menopause due to reduced estrogen levels.
• Obesity: A body mass index (BMI) of 30 or higher significantly increases the risk of gout.
• Metabolic syndrome: This cluster of conditions—including high blood pressure, high blood sugar, excess abdominal fat, and abnormal cholesterol or triglyceride levels—elevates the risk for heart disease, stroke, type 2 diabetes, and gout.
• Decreased kidney function: Impaired kidney function reduces the body's ability to excrete uric acid.
• Congestive heart failure: This condition can also impact uric acid metabolism and excretion.
• Genetics or family history: A family history of gout increases individual susceptibility.
• Heavy alcohol consumption: Alcohol, especially beer, is a significant source of purines and can impede uric acid excretion.
• A diet high in purine-rich foods: Regular consumption of red meats, organ meats (like liver), and certain seafood (e.g., anchovies, sardines) can elevate uric acid levels.
• Excessive use of water pills (diuretics): Some diuretics can increase uric acid levels in the blood.

Diagnosis: A Differentiated Approach

Diagnosing inflammatory arthritis can be complex, as various conditions share similar symptoms. For both psoriatic arthritis and gout, a precise diagnosis is paramount to initiating appropriate treatment and preventing long-term joint damage. While high blood levels of uric acid can point towards gout, this alone is not definitive, as individuals with psoriasis and PsA may also exhibit elevated uric acid levels without necessarily having gout. Therefore, healthcare providers employ a range of diagnostic methods, including symptom assessment, physical examination, laboratory tests, and imaging, to accurately distinguish between these conditions and rule out others.

Psoriatic Arthritis

An early and accurate diagnosis of PsA is critical to prevent irreversible joint damage and deformity. The diagnostic process typically involves a detailed discussion of symptoms and medical history, a thorough physical examination, specific laboratory tests, and imaging studies.

• Symptoms: Your doctor will ask about the nature, duration, and triggers of your symptoms. The presence of characteristic skin and nail symptoms commonly associated with psoriasis is often a key indicator for PsA.
• Medical and family history: Providing a comprehensive medical history, particularly any record of psoriasis or a family history of psoriatic disease, is essential for guiding the diagnosis.
• Physical examination: The physician will carefully examine your joints and tendons for signs of swelling, tenderness, and inflammation. They will also inspect your fingernails and toenails for the distinctive changes seen in PsA.
• Blood work: Several blood tests are utilized. Erythrocyte sedimentation rate (ESR) indicates general inflammation but is not specific to PsA. Rheumatoid factor (RF) and anti-CCP antibody testing are crucial for ruling out rheumatoid arthritis (RA), as these markers are typically elevated in RA but negative in PsA. HLA-B27 testing may be performed to identify a genetic marker often associated with PsA involving the spine.
• Imaging: X-rays, magnetic resonance imaging (MRI), and ultrasound scans can reveal bone changes or joint damage. In PsA, doctors specifically look for early signs of joint damage in the hands, feet, and spine, areas commonly affected.
• Joint aspiration: To definitively rule out gout, your doctor may perform a joint aspiration. This procedure involves using a needle to draw a sample of fluid from an affected joint. If uric acid crystals are observed under a microscope, gout is highly probable.

Gout

The diagnosis of gout is typically established based on the patient's symptoms and the distinct appearance of the inflamed joints. To confirm the diagnosis and exclude other potential conditions, your healthcare provider may also order specific tests.

• Joint fluid test: A joint aspiration is considered the most accurate diagnostic test for gout. When the aspirated joint fluid is examined under a microscope, the presence of urate crystals provides a definitive diagnosis.
• Blood work: A blood test to measure uric acid levels is a common diagnostic step. However, it's important to recognize that uric acid levels can be misleading; many individuals may have high levels without ever developing gout, while some with clear gout symptoms may have normal uric acid levels during an attack.
• Imaging: X-rays of affected joints can be helpful in ruling out other causes of joint pain and swelling. Ultrasound imaging has also proven valuable in detecting urate crystals within the joints and identifying tophi deposits, even those not yet visible externally.

Treatment: Managing Symptoms and Preventing Progression

While there is currently no definitive cure for either psoriatic arthritis or gout, both conditions are highly manageable with effective treatment strategies. The primary goals of treatment are to alleviate pain, reduce inflammation, control symptoms, and crucially, prevent further joint damage and associated complications. Treatment plans are tailored to the individual, considering the severity of their condition, the specific type of PsA or gout, and the presence of any existing joint damage.

Psoriatic Arthritis

Treatment for PsA is often progressive, beginning with milder interventions and escalating to more potent therapies as needed, depending on disease severity and the impact on joints.

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): For individuals with mild disease who have not yet experienced significant joint damage, NSAIDs such as Advil or Motrin (ibuprofen) and Aleve (naproxen) are often the initial line of treatment. These medications help reduce pain and inflammation.
• Conventional Disease-Modifying Antirheumatic Drugs (DMARDs): For those with more active disease, experiencing frequent pain, swelling, and skin symptoms, conventional DMARDs like Trexall (methotrexate) are considered second-line therapies. These drugs work by modulating the immune system to prevent damage to the joints, spine, and tendons.
• Biologics: For individuals who have experienced joint damage from PsA or whose symptoms are not adequately controlled by conventional DMARDs, biologic medications can be highly effective. These targeted therapies specifically block inflammatory pathways in the immune system, thereby slowing down disease progression.
• Janus Kinase (JAK) Inhibitors: The newest class of treatments for PsA, JAK inhibitors, work by suppressing specific immune signals. They help to dampen the overall immune response, which in turn reduces joint pain and swelling and prevents further joint damage.
• Additional treatment options: Beyond medication, comprehensive care for PsA may include:
  • Physical therapy: To improve range of motion, reduce symptoms, strengthen supporting muscles, and stabilize the spine.
  • Topical treatments: For managing psoriasis skin symptoms.
  • Phototherapy: A light-based therapy, also used to treat psoriasis skin symptoms.

Gout

Gout treatment primarily focuses on two objectives: rapidly alleviating the pain and inflammation during an acute gout attack, and preventing future attacks and complications by reducing the levels of uric acid in the blood.

Medications to help reduce symptoms of acute gout attacks include:

• NSAIDs: Nonsteroidal anti-inflammatory drugs are used to quickly reduce the intense pain and swelling characteristic of a gout flare.
• Mitigare (colchicine): If taken within 24 hours of the onset of a gout attack, colchicine can significantly reduce inflammation and pain.
• Corticosteroids: These powerful anti-inflammatory medications can be administered orally or via injection into the affected joint to rapidly relieve pain and swelling, especially when NSAIDs or colchicine are not suitable or effective.

Drugs specifically designed to lower uric acid levels in the body and prevent future gout attacks include:

• Alloprin (allopurinol): A commonly prescribed oral medication that reduces the body's production of uric acid.
• Uloric (febuxostat): Another oral medication that inhibits uric acid production, often used when allopurinol is not tolerated.
• Benemid (probenecid): An oral medication that helps the kidneys excrete more uric acid from the body.
• Krystexxa (pegloticase): An intravenous infusion medication typically reserved for severe, chronic gout that has not responded to other treatments, working to break down uric acid into a more easily excreted form.

While medication forms the cornerstone of gout management, lifestyle and dietary modifications are also crucial for maintaining long-term control:

• Choosing healthy beverages: Limiting or avoiding alcohol (especially beer and spirits) and drinks sweetened with high-fructose corn syrup is essential, as these can significantly elevate uric acid levels.
• Avoiding foods high in purines: Consuming red meats, organ meats (like liver), and certain purine-rich seafood (such as anchovies and sardines) should be minimized, as they contribute to higher uric acid levels.

Prevention: Managing Risk and Symptoms

While the onset of inflammatory arthritis conditions like psoriatic arthritis and gout is rarely entirely preventable, especially for those with genetic predispositions, proactive management can significantly reduce the frequency and severity of flare-ups and attacks. Researchers continue to identify risk factors, but no treatments or preventive measures can guarantee that an individual will never develop PsA or gout.

Given that some individuals experience both psoriatic arthritis and gout, it is particularly important for those diagnosed with PsA to be vigilant for any signs of gout. Effective management of stress, adherence to a healthy diet, maintaining an active lifestyle, and consistently following the prescribed treatment plan are the most effective strategies for preventing symptom flare-ups and attacks in both conditions. These proactive measures empower individuals to take an active role in protecting their joint health and improving their overall quality of life.

Summary

Psoriatic arthritis and gout are two distinct forms of inflammatory arthritis that can sometimes be confused due to shared symptoms, particularly pain and swelling in the fingers and toes. However, their underlying mechanisms differ significantly: PsA results from an autoimmune malfunction where the immune system attacks joint tissues, whereas gout arises from the accumulation of uric acid in the blood, leading to crystal formation in the joints.

Key diagnostic tests, such as specialized blood work and joint fluid aspiration, are crucial for differentiating between these conditions. Although neither condition is entirely preventable, both are manageable and treatable. With appropriate medical intervention and lifestyle adjustments, individuals can effectively control their symptoms and minimize long-term impact on joint health.

A Word From Verywell

Experiencing persistent joint pain or stiffness warrants a prompt consultation with a rheumatologist. These specialized physicians are experts in diagnosing and managing arthritis, other musculoskeletal conditions, and systemic autoimmune diseases. While many types of arthritis may present with similar symptoms, they represent distinct diagnoses, each requiring a tailored approach to treatment.

Even though certain treatments might overlap, every form of arthritis demands a comprehensive evaluation and a specific treatment plan to ensure optimal outcomes. If you receive a diagnosis of psoriatic arthritis or gout, adhering to your treatment regimen and actively managing these conditions is paramount to protecting your joints from progressive damage. Early and aggressive treatment can significantly mitigate joint deterioration and profoundly enhance your quality of life.

Sources

Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.

1. Ogdie A, Weiss P. The epidemiology of psoriatic arthritis. Rheum Dis Clin North Am. 2015;41(4):545-568. doi:10.1016/j.rdc.2015.07.001
2. National Psoriasis Foundation. Psoriasis statistics. Updated October 8, 2020.
3. Johns Hopkins Arthritis Center. Symptoms and diagnosis of gout
4. Avhad G, Ghuge P. Podagra. Indian Dermatol Online J. 2014;5(Suppl 2):S134-S135. doi:10.4103/2229-5178.146196
5. Fargetti S, Goldenstein-Schainberg C, Silva Abreu A, Fuller R. Refractory gout attack. Case Rep Med. 2012;2012:657694. doi:10.1155/2012/657694
6. Cardoso FN, Omoumi P, Wieers G, et al. Spinal and sacroiliac gouty arthritis: report of a case and review of the literature. Acta Radiol Short Rep. 2014;3(8):2047981614549269. doi:10.1177/2047981614549269
7. Gisondi P, Targher G, Cagalli A, Girolomoni G. Hyperuricemia in patients with chronic plaque psoriasis. J Am Acad Dermatol. 2014 Jan;70(1):127-30. doi:10.1016/j.jaad.2013.09.005
8. Merola JF, Wu S, Han J, Choi HK, Qureshi AA. Psoriasis, psoriatic arthritis and risk of gout in US men and women. Ann Rheum Dis. 2015;74(8):1495-1500. doi:10.1136/annrheumdis-2014-205212
9. MedlinePlus. Psoriatic arthritis. Updated August 18, 2020.
10. Ogdie A, Gelfand JM. Clinical risk factors for the development of psoriatic arthritis among patients with psoriasis: a review of available evidence. Curr Rheumatol Rep. 2015;17(10):64. doi:10.1007/s11926-015-0540-1
11. Cleveland Clinic. Psoriatic arthritis. Updated November 29, 2019.
12. MedlinePlus. Gout. Updated September 29, 2020.
13. Cleveland Clinic. Gout. Updated November 15, 2020.
14. Belasco J, Wei N. Psoriatic arthritis: What is happening at the joint?. Rheumatol Ther. 2019;6(3):305-315. doi:10.1007/s40744-019-0159-1

By Lana Barhum Barhum is a medical writer with 15 years of experience with a focus on living and coping with chronic diseases.
See Our Editorial Process
Meet Our Medical Expert Board